Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1192526/full |
| _version_ | 1827968208502521856 |
|---|---|
| author | Xing Bian Xing Bian Xing Bian Xing Bian Xiaolin Wang Xiaolin Wang Xiaolin Wang Xiaolin Wang Qiuyan Zhang Liying Ma Liying Ma Liying Ma Liying Ma Guozhen Cao Guozhen Cao Guozhen Cao Guozhen Cao Ao Xu Ao Xu Jinhua Han Jun Huang Wenchu Lin Wenchu Lin Wenchu Lin |
| author_facet | Xing Bian Xing Bian Xing Bian Xing Bian Xiaolin Wang Xiaolin Wang Xiaolin Wang Xiaolin Wang Qiuyan Zhang Liying Ma Liying Ma Liying Ma Liying Ma Guozhen Cao Guozhen Cao Guozhen Cao Guozhen Cao Ao Xu Ao Xu Jinhua Han Jun Huang Wenchu Lin Wenchu Lin Wenchu Lin |
| author_sort | Xing Bian |
| collection | DOAJ |
| first_indexed | 2024-04-09T18:18:34Z |
| format | Article |
| id | doaj.art-24eb4f9d8bee44e6862d57156e58f9e5 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-04-09T18:18:34Z |
| publishDate | 2023-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-24eb4f9d8bee44e6862d57156e58f9e52023-04-12T15:06:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-04-011310.3389/fonc.2023.11925261192526Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancerXing Bian0Xing Bian1Xing Bian2Xing Bian3Xiaolin Wang4Xiaolin Wang5Xiaolin Wang6Xiaolin Wang7Qiuyan Zhang8Liying Ma9Liying Ma10Liying Ma11Liying Ma12Guozhen Cao13Guozhen Cao14Guozhen Cao15Guozhen Cao16Ao Xu17Ao Xu18Jinhua Han19Jun Huang20Wenchu Lin21Wenchu Lin22Wenchu Lin23High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, ChinaUniversity of Science and Technology of China, Hefei, ChinaKey Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, ChinaHigh Magnetic Field Laboratory of Anhui Province, Hefei, ChinaHigh Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, ChinaUniversity of Science and Technology of China, Hefei, ChinaKey Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, ChinaHigh Magnetic Field Laboratory of Anhui Province, Hefei, ChinaThe CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Signaling Network, School of Life Sciences, University of Science and Technology of China, Hefei, ChinaHigh Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, ChinaUniversity of Science and Technology of China, Hefei, ChinaKey Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, ChinaHigh Magnetic Field Laboratory of Anhui Province, Hefei, ChinaHigh Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, ChinaUniversity of Science and Technology of China, Hefei, ChinaKey Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, ChinaHigh Magnetic Field Laboratory of Anhui Province, Hefei, ChinaThe First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, ChinaDepartment of Pathology, Anhui Provincial Hospital, Hefei, ChinaMOE Key Laboratory for Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, ChinaMOE Key Laboratory for Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, ChinaHigh Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, ChinaKey Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, ChinaHigh Magnetic Field Laboratory of Anhui Province, Hefei, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2023.1192526/fullsmall cell lung cancerMYC paralogPARP1BETDNA damage response |
| spellingShingle | Xing Bian Xing Bian Xing Bian Xing Bian Xiaolin Wang Xiaolin Wang Xiaolin Wang Xiaolin Wang Qiuyan Zhang Liying Ma Liying Ma Liying Ma Liying Ma Guozhen Cao Guozhen Cao Guozhen Cao Guozhen Cao Ao Xu Ao Xu Jinhua Han Jun Huang Wenchu Lin Wenchu Lin Wenchu Lin Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer Frontiers in Oncology small cell lung cancer MYC paralog PARP1 BET DNA damage response |
| title | Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer |
| title_full | Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer |
| title_fullStr | Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer |
| title_full_unstemmed | Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer |
| title_short | Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer |
| title_sort | corrigendum the myc paralog parp1 axis as a potential therapeutic target in myc paralog activated small cell lung cancer |
| topic | small cell lung cancer MYC paralog PARP1 BET DNA damage response |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1192526/full |
| work_keys_str_mv | AT xingbian corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT xingbian corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT xingbian corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT xingbian corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT xiaolinwang corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT xiaolinwang corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT xiaolinwang corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT xiaolinwang corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT qiuyanzhang corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT liyingma corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT liyingma corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT liyingma corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT liyingma corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT guozhencao corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT guozhencao corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT guozhencao corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT guozhencao corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT aoxu corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT aoxu corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT jinhuahan corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT junhuang corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT wenchulin corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT wenchulin corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer AT wenchulin corrigendumthemycparalogparp1axisasapotentialtherapeutictargetinmycparalogactivatedsmallcelllungcancer |